MARCIA EDWARDS: Open Payments
NPI 1447837851 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 47 payments from 12 companies in 2025. Trend: 2023 $1,326 · 2024 $687 · 2025 $1,076
Food & beverage: $1,076
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $270 |
| Janssen Pharmaceuticals, Inc | 7 | $192 |
| Almatica Pharma LLC | 5 | $112 |
| Lundbeck LLC | 4 | $103 |
| Teva Pharmaceuticals USA, Inc. | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Neurocrine BioSciences, Inc. | 2 | $70 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Braeburn Inc. | 1 | $22 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, LOREEV XR, INGREZZA, UZEDY, Auvelity, COBENFY.
Industry payments across FL — which companies pay providers there.
